January new home sales plunge to the lowest pace since 2022

January new home sales plunge to the lowest pace since 2022


Blaine, Minnesota. New homes starting at a half million dollars in Lexington Waters are high efficiency homes and are HOA Maintained. 

Michael Siluk | UCG | Universal Images Group | Getty Images

Sales of newly built homes in January dropped 17.6% month over month to a seasonally adjusted, annualized pace of 587,000 units, according to the U.S. Census Bureau. That is the slowest pace since 2022.

Housing analysts had been expecting a much smaller decline.

Sales were also 11.3% lower than in January 2025, according to the U.S. Census, which is still delayed in its reporting due to last year’s government shutdown. December sales were also revised lower.

This count is based on signed contracts, so people who were out shopping when mortgage rates were lower than they are today. The average rate on the 30-year fixed loan hovered between 6% and 6.2% during January, according to Mortgage News Daily. It is currently at 6.36%.

As a result, the inventory of homes for sale rose to a 9.7-month supply, up from eight months in December, according to the U.S. Census. That is 7.8% higher than January 2025.

More supply and less demand led builders to drop prices. The median price of a home sold in January was $400,500, the agency said, a decline of 6.8% year over year. Prices for existing homes are still flat nationally, but builders report increasing incentives to get buyers in the door.

Data from March does not appear to be any better. An estimated 37% of builders cut prices in March, an increase from February’s 36%, according to the National Association of Home Builders.

Sales were lower across the nation, but they dropped the most in the Northeast and Midwest, where rough winter weather could have had an impact. However, sales were down nearly 22% from December in the West, where weather would not have played a part.

Get Property Play directly to your inbox

CNBC’s Property Play with Diana Olick covers new and evolving opportunities for the real estate investor, delivered weekly to your inbox.

Subscribe here to get access today.

Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.



Source

More than 20,000 people are taking Eli Lilly’s weight loss pill Foundayo, CEO says
Business

More than 20,000 people are taking Eli Lilly’s weight loss pill Foundayo, CEO says

More than 20,000 people have started taking Eli Lilly‘s GLP-1 pill Foundayo in its first few weeks on the market, Lilly CEO Dave Ricks told CNBC on Thursday. The FDA approved Lilly’s once-daily pill Foundayo earlier this month, making it the second oral GLP-1 drug behind Novo Nordisk’s Wegovy pill. Investors have been closely tracking […]

Read More
Lawyers to the wealthy warn that AI legal advice comes with serious risks
Business

Lawyers to the wealthy warn that AI legal advice comes with serious risks

Displeased couple having problems during a meeting with their agent in the office. Skynesher | E+ | Getty Images A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. Lawyer Tasha Dickinson said […]

Read More
Eli Lilly blows past quarterly estimates, hikes outlook as Zepbound and Mounjaro sales skyrocket
Business

Eli Lilly blows past quarterly estimates, hikes outlook as Zepbound and Mounjaro sales skyrocket

David Ricks, chief executive officer of Eli Lilly & Co., at the Semafor World Economy Summit during the International Monetary Fund (IMF) and World Bank Spring meetings in Washington, DC, US, on Friday, April 17, 2026. Aaron Schwartz | Bloomberg | Getty Images Eli Lilly on Thursday reported first-quarter earnings and revenue that blew past […]

Read More